UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Apr

    24

    UCB Volunteers Help Communities Impacted by COVID-19

    Serving others is in our DNA at UCB – from committing to patients in our daily jobs to finding ways to make a difference in our communities through volunteerism. Each year, UCB employees get 32-hours of time off to volunteer their time at non-profits of their choice, and COVID-19 has not slowed us down from using those hours to help others during this difficult time. This National Volunteer Week, we’re celebrating our employees, whose selfless efforts during this COVID-19 pandemic inspire us.

    Apr

    22

    Minimizing Our Environmental Footprint

    During the COVID-19 pandemic, we’re reminded of the many challenges facing our world. At UCB, we recognize the challenges facing the world, from climate change to rising inequalities, are inextricably linked and that businesses have a key role to play to ensure a sustainable future for all. This Earth Day, we’re highlighting some of our progress as it relates to minimizing our environmental footprint across the value chain.

    Apr

    10

    UCB’s Three-Point Plan to Help Combat COVID-19 in the U.S.

    With the U.S. heavily impacted by the novel coronavirus, COVID-19, UCB is committed to playing our part to contribute our scientific expertise and resources to the greater response effort happening across the country and the world. This includes expanding our assistance programs to further help patients impacted by the pandemic.

    Apr

    02

    UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients

    UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients.